Stock Information
Investor and Media Relations
Anthony Marciano
Head of Corporate Communications
Seelos Therapeutics, Inc.
anthony.marciano@seelostx.com
Offices
Seelos Therapeutics, Inc.
300 Park Avenue
New York, NY 10022
Incorporated
Nevada
Entity type
Corporation
Identifiers
CIK:1017491
IRS:870449967
Receive Email Alerts
Seelos Sitemap
Overview
Seelos Therapeutics, Inc. (Nasdaq: SEEL) is a responsibly-driven company focused on achieving the most efficient development of products that address significant unmet needs in CNS disorders and in rare diseases.